Business Context and Reporting Period
Trulieve Cannabis Corp. filed a Current Report on Form 8-K dated June 10, 2021, reporting matters approved at its annual shareholder meeting and adoption of its 2021 Omnibus Incentive Plan. The report was signed on June 11, 2021.
Key Financial Metrics and Capitalization
The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating performance metrics. As of December 31, 2020, the Company reported approximately 5,000 employees and seven non-employee directors.
Material Changes Versus the Prior Comparable Period
- Shareholders approved the 2021 Omnibus Incentive Plan, reserving 4,000,000 Subordinate Voting Shares for awards.
- The 2021 Plan replaces the Schyan Exploration Inc. Stock Option Plan. Existing awards under the prior plan remain outstanding, but no additional awards may be granted under it.
- The new plan permits stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards, other stock-based awards, and cash-based awards.
- The plan generally provides for equity-award vesting or settlement upon a change in control, subject to exceptions for replacement awards assumed by a surviving entity.
Guidance, Outlook, Commentary, Risks, and Unusual Items
- Management stated that shareholder approval supports equity compensation as an important component of the compensation program and is intended to align employees, officers, directors, and other service providers with shareholders.
- Annual equity and cash-based awards to any non-employee director are limited to $750,000.
- Options and stock appreciation rights generally must have an exercise or grant price at least equal to fair market value on the grant date and may have terms of up to ten years.
- Awards may be forfeited or recouped under the plan. Involuntary termination for cause generally results in forfeiture of specified outstanding awards.
- The filing provides no financial guidance or operating outlook. Potential dilution from the 4,000,000-share reserve and future awards should be considered.
Annual Meeting Results
| Proposal | Result |
|---|---|
| Set the number of directors at eight | Approved: 86,280,598 for; 124,578 against; 1,066,894 abstain |
| Election of eight director nominees | All nominees re-elected; votes for ranged from 77,215,799 to 77,852,931 |
| 2021 Omnibus Incentive Plan | Approved: 75,610,892 for; 2,456,553 against; no abstentions; 9,404,625 broker non-votes |
| Ratification of MNP LLP as independent registered public accounting firm for fiscal 2021 | Ratified: 87,084,507 for; none against; 387,563 withheld |
Important Facts for Investors to Verify
- Review Exhibit 10.1 for the complete terms, award limits, share recycling provisions, and change-in-control treatment under the 2021 Plan.
- Assess the potential effect of the 4,000,000-share reserve and liberal share-recycling provisions on future dilution.
- Confirm the current status and remaining awards under the Prior Plan, including awards granted in the first quarter of 2021 for 2020 performance.
- Verify director voting results, broker non-votes, and the continued service of all eight directors.
- Review subsequent filings for actual grants, exercises, forfeitures, or settlements under the 2021 Plan.